Up a level |
Dang, Nam H. and Ogura, Michinori and Castaigne, Sylvie and Fayad, Luis E. and Jerkeman, Mats and Radford, John and Antonio, Antonio and Bondarenko, Igor and Stewart, Douglas A and Shnaidman, Michael and Sullivan, DR. Sharon and Vandendries, Erik and Tobinai, Kensei and Ramchandren, Radhakrishnan and Hamlin, Paul A. and Giné, Eva and Ando, Kiyoshi (2018) Randomized, phase 3 trial of inotuzumab ozogamicin plus rituximab versus chemotherapy plus rituximab for relapsed/ refractory aggressive B-cell non-Hodgkin lymphoma. British Journal of Haematology, 182 (4). pp. 583-586. ISSN 1365-2141